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Migration patterns in modern societies have created the opportunity to use population admixture as a strategy to identify
susceptibility genes. To implement this strategy, we genotyped a highly informative ancestry marker panel of 2270 single
nucleotide polymorphisms in a random population sample of African Americans (N=1743), European Americans (N=1000) and
Mexican Americans (N=581). We then examined the evidence for over-transmission of specific loci to cases from one of the
two ancestral populations. Hypertension cases and controls were defined based on standard clinical criteria. Both case-only
and case-control analyses were performed among African Americans. With the genome-wide markers we replicated the
findings identified in our previous admixture mapping study on chromosomes 6 and 21 [1]. For case-control analysis we then
genotyped 51 missense SNPs in 36 genes spaced across an 18.3 Mb region. Further analyses demonstrated that the missense
SNP rs2272996 (or N131S) in the VNN1 gene was significantly associated with hypertension in African Americans and the
association was replicated in Mexican Americans; a non-significant opposite association was observed in European Americans.
This SNP also accounted for most of the evidence observed in the admixture analysis on chromosome 6. Despite these
encouraging results, susceptibility loci for hypertension have been exceptionally difficult to localize and confirmation by
independent studies will be necessary to establish these findings.
Citation: Zhu X, Cooper RS (2007) Admixture Mapping Provides Evidence of Association of the VNN1 Gene with Hypertension. PLoS ONE 2(11): e1244.
doi:10.1371/journal.pone.0001244
INTRODUCTION
Hypertension is a consequence of common lifestyle patterns in
modern society and makes an important contribution to risk of
cardiovascular disease. The prevalence of hypertension varies
among ethnic populations in the US from 25 to 40% and is an
attributable cause for approximately 13% of deaths in whites and
24% in blacks [2]. Blood pressure is a moderately heritable trait
and results from the combined effect of a complex set of genetic
and environmental influences, with genes cumulatively accounting
for 30% of the population variance [3]. Genome-wide linkage
analysis has been widely applied in efforts to identify genomic
regions harboring genes affecting the risk of hypertension. A recent
review of 20 genome scans suggested that a large number genes,
each exerting a small effect, is the most likely molecular
architecture underlying hypertension [4]. The observed effects
are highly inconsistent, however, and it is well recognized that
linkage analysis has limited power when applied to complex traits
[5]; locus heterogeneity may further contribute to this observed
inconsistency.
As an alternative to linkage methods, numerous candidate genes
selected on physiological and/or metabolic criteria have been
examined using single nucleotide polymorphisms (SNPs) or
associated haplotypes. Despite the myriad of reports, meta-
analyses have identified few candidate loci with consistent effects
across population samples [6]. For example, the genes underlying
physiologic systems that control BP, like the renin-angiotensin axis,
have been extensively studied, and yielding inconsistent results
[7,8]. Genome-wide association studies based on 100,000 or more
SNPs are now technically feasible [9,10] and initial results with
macular degeneration, obesity, type 1 and type 2 diabetes, prostate
cancer and multiple sclerosis, among others, suggest promise for
this method [11–19]. These studies are still quite expensive,
however, and can only be conducted by a limited number of
laboratories.
On the basis of recent theoretical work it has been suggested
that the information generated by recent admixture of historically
separated populations can help to map disease-associated genes
[20–29]. Admixture mapping can be more powerful than
traditional linkage analysis when the relative risk in the parental
populations is substantially different and much less genotyping is
required in comparison to association analysis based on linkage
disequilibrium. Admixture mapping may also be less sensitive to
genetic heterogeneity [30]. Based on these theoretical proposi-
tions, Zhu et al. performed the first large-scale genome wide
admixture mapping study in African Americans using the markers
designed for a family-based linkage study [1]. In these analyses the
distribution of marker location-specific ancestry was shifted
upward in hypertensive cases versus normotensives and this shift
was largely due to the loci on 6q24 and 21q21, indicating that
genetic variants in these two regions may influence the risk of
hypertension. Since the marker information content for inferring
ancestry was relatively low in this initial study, the findings require
further confirmation. Consequently using a large, multi-ethnic
population sample, we conducted an admixture mapping study by
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PLoS ONE | www.plosone.org 1 November 2007 | Issue 11 | e1244genotyping a marker panel that is highly informative for ancestry
for the African-American population [31]. In this paper we
describe the admixture linkage results for hypertension in the
Dallas Heart Study, followed by an association study of all
missense SNPs in the region identified by the admixture mapping.
RESULTS
The demographic and descriptive characteristics of the hyperten-
sive cases and controls are presented in Table 1 for the European-
American, African-American and Mexican-American population
samples. Cases were on average older than controls in all three
groups, as anticipated; the percentage of treated cases was similar.
Admixture mapping in African-Americans
2,270 ancestry informative SNPs located on 22 autosomes selected
from the SNP panel of Smith et al.[31] were successfully
genotyped. After examination of Hardy-Weinberg equilibrium
(HWE) for possible genotyping errors and background linkage
disequilibrium which may violate the assumption of the method
[25], only 1,890 SNPs were used in further analyses. Our analysis
used the software ADMIXPROGRAM, which is based on the
hidden Markov model using the continuous gene flow model [25].
The estimated number of generations since the occurrence of
population admixture was 12 in this African-American sample.
We estimated each individual’s average African and European
ancestries (Table S1)(European ancestry=15.867.6% in cases,
and 16.968.3% in controls) as well as ancestry at each marker
locus in cases and controls separately (Table S2). We then
calculated the genome-wide case-only and case-control Z scores,
as presented in figure 1. The Z score can be used to evaluate
evidence for a disease variant at each location and it asymptot-
ically follows the standard normal distribution [21,25]. We
observed 6 markers with both |Zcase| and |Zcase-control|.2.0
distributed on 6 chromosomes (Table 2). Among them, the signal
identified by SNP rs703193 (137cM) on chromosome 6 falls within
the region identified in our previous study [1]. To further rule out
that the possibility that the evidence observed on chromosome 6
results from the bias resulting either from mis-estimation of
a specific marker allele’s frequency in ancestral populations or
background linkage disequilibrium, we calculated both the case-
only and case-control Z scores using different sets of SNPs as
suggested by Reich et al. [32] (Table 3). Similar evidence was
observed at rs703193 when we used the SNPs with an adjacent
distance greater than 1 cM. The evidence remains when either
odd SNPs or even SNPs were used. Gender-specific analysis
suggested that women contribute more evidence, which may in
part reflect the inclusion of more hypertensive women in the study
(Table 1). The relative risk of hypertension due to two copies of
African ancestry allele in the region around SNP rs703193 was
1.32 (95% CI: (1.04, 1.67), p=0.023). We also examined the
region on chromosome 21 identified in our previous study [1].
Interestingly, the admixture mapping evidence in the region
around rs380417 on chromosome 21 was weaker than on
chromosome 6q, but with a stronger relative risk of African
ancestry at rs380417=1.48 (viz, 95%CI: (1.15, 1.89), p=0.0021).
We next empirically explored the probability of Zcase and
Zcase-control scores greater than we observed on chromosome 6 and
21 in the African-American sample when no genetic variants
contributed to a trait. We applied a one-sided test for the African-
American sample because of previous evidence in this region. We
then simulated 1,000 data sets for both samples with the estimated
parental allele frequencies and 12 generations based on a contin-
uous gene flow model [21]. The numbers of analyses with
Zcase.2.1, Zcase-control.2.8 for chromosome 6, and Zcase.2.1,
Zcase-control.1.4 for chromosome 21, were summarized. Among
1,000 simulations, we observed 184 instances where both
Zcase.2.1, Zcase-control.2.8 and 688 instances where both
Zcase.2.1 and Zcase-control.1.4 respectively, indicating that our
observations on both 6q and 21q do not reach genome-wide
significance. However, when we restricted the analysis to the
regions between 129–166 cM on chromosome 6 and between 0–
30 cM on chromosome 21 identified in our previous study [1], we
only observed 4 and 11 instances respectively (p=0.004 and
0.011), suggesting that our results do in fact replicate the previous
findings. We performed similar analyses with the other 5 regions,
using a two-side test since no prior evidence was observed in these
regions, and none reached genome-wide significance (Table 2).
We performed similar analysis using the software STRUC-
TURE. Among the African Americans, European ancestry was
estimated as 15.8%68.3% in cases, and 17.069.1% in controls,
which are the same as we obtained with ADMIXPROGRAM.
The detailed European ancestry for each individual estimated by
both methods is presented in Supplement Table S1. The
correlation between the two methods is 99.96%. We also
calculated the case-only and case-control Z scores by excluding
the estimates of an individual’s marker-location specific ancestry if
the difference of the estimates between the two methods is greater
than 0.1. No substantial changes in the Z scores were observed
(Table S2).
Association analysis on chromosome 6
We next focused on the region around rs703193 defined by
Zcase.1.0 on chromosome 6 which encompassed 18.3 Mb and 36
genes. We hypothesized that missense SNPs are more likely
responsible for the evidence identified by admixture mapping
[5,33]. We identified 51 missense SNPs in the 36 genes from
Table 1. Descriptive characteristics of the study subjects from each of racial/ethnic groups (means6sd)
..................................................................................................................................................
Control Case
Black White Mexican American Black White Mexican American
Number (male/fem) 880 (389/491) 662 (316/346) 453 (192/261) 863 (347/516) 338 (162/176) 128 (53/75)
Age 40.869.3 43.369.7 38.768.1 48.869.4 47.969.9 45.9610.1
BMI 29.267.2 27.165.9 28.965.6 31.767.7 30.867.0 32.167.1
SBP 119.7613.4 117.9612.3 116.6611.3 143.1624.8 136.7617.2 138.5619.8
DBP 75.569.0 74.768.0 73.867.5 86.4614.0 84.6611.0 83.969.6
No. Treated 0 0 0 663 (76.8%) 255(75.4%) 94(73.4)
doi:10.1371/journal.pone.0001244.t001
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Figure 1. The genome-wide Z-scores. Top: the Z-scores calculated using hypertensive cases only ; Bottom: the Z-scores calculated based on case-
control samples.
doi:10.1371/journal.pone.0001244.g001
Table 2. Marker locations with the maximum absolute Z score larger than 2.0 for association with hypertension
..................................................................................................................................................
Marker Location (cM)
Excess of African
Ancestry in cases
African-
American Zcase
African-American
Zcase-control
Genome-wide
p-value
a
Rs428854 1p: 73.7 0.018 2.2 2.8 0.58
Rs184008 4q:81.8 20.024 22.9 22.2 0.49
Rs703193 6q:137 0.018 2.1 2.8 0.18
b
rs784037 8q:74.8 20.018 22.1 22.5 0.80
Cv490881 16q:106 20.026 23.2 22.0 0.34
Cv118741 17q:105 20.020 22.4 22.3 0.80
Rs380417 21q: 26 0.017 2.1 1.4 0.66
b
aThe genome-wide p-value was calculated by the number of times with |Zcase|, |Zcase-control| in African-Americans greater than the corresponding observed Z scores
among the 1000 simulations.
bThe p value was calculated using one-side test.
doi:10.1371/journal.pone.0001244.t002
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PLoS ONE | www.plosone.org 3 November 2007 | Issue 11 | e1244public databases and typed them in the African-American sample
(Figure 2). Eight of these SNPs were found to have a MAF,5%
and an additional 4 were in strong HWD (p,0.01). Admixture
mapping has extremely limited power to identify rare variants so
these 12 SNPs were excluded from further analyses. We performed
logistic regression on each of the remaining 39 SNPs assuming an
additive model with adjustment for gender, age, BMI and
estimated individual ancestry (IA) based on the original 1890
marker panel. We chose to focus only on the additive model in this
step because the reduction of multiple comparisons more than
compensates for the small sacrifice in power associated with this
strategy.
We also adjusted for IA to reduce the likelihood of false
association that results from population stratification. Association
with hypertension was identified at a=0.05 significance level at
rs2244008 (A/G) and rs2272996(C/T) in the LAMA2 and VNN1
genes, respectively (Table 4). We then examined whether these
two SNPs captured the evidence from admixture mapping. First,
we attempted to isolate the ancestry effect. After inferring each
individual’s ancestry at the admixture peak (137cM) we repeated
the logistic regression analysis in the subgroup whose African
ancestry was .80% at this locus, assuming that this reduced any
potential effects of population stratification. While the result for
rs2244008 was unchanged, the association of rs2272996 with
hypertension was strengthened (p=0.00248) despite the reduction
in sample size. Based on a permutation test this SNP remained
significant (p=0.045) after adjustment for multiple comparisons
(See Methods). SNP rs2272996 is located 3.6 Mb from rs703193,
with virtually no linkage disequilibrium between these two SNPs
(D’=0.008, 95% CI (20.01–0.12)). To determine if two SNPs
with this relationship can potentially be in LD in an admixed
population similar to African-Americans, we calculated the LD
between these two SNPs in a synthetic admixed population using
HapMap YRI and CEU date. We assumed that the admixture
proportions were 84% African and 16% European. Under these
conditions D’ was estimated as 0.095, which is within the 95% CI
of the finding in our data, suggesting that an AIM used for
admixture mapping is not necessarily in strong LD with a SNP
associated with the phenotype. We also performed logistic
regression for SNP rs703193 adjusting for gender, age, BMI and
IA and no evidence of association was found. To further evaluate
the plausibility of the evidence for rs2244008 we compared the
allele frequency between YRI and CEU samples from HapMap
data [10], as well as in our own European-American sample. The
frequencies were almost the same, confirming that this SNP is
unlikely to account for the evidence observed by the admixture
mapping. In contrast, for rs2272996 the allele frequencies were
substantially different between YRI and CEU and between YRI
and our own European-American sample (Table 4). Further
analysis suggested that applying a recessive model rs2272996 (TT
vs TC and CC) yielded the most significant association, with
hypertension risk increased in the presence of the TT genotype
(p=0.0021, Table 5). Further correction for multiple comparisons
of 39 SNPs and additive and recessive modes of inheritance
yielded a p-value of 0.06 for rs2272996. We therefore hypothe-
sized that the excess of African ancestry at the peak location
(137cM) in cases was accounted for by those who carried the TT
Table 3. Zcase and Zcase-control scores at rs703193 when
different set of ancestral informative SNPs are used.
......................................................................
Excess of African
Ancestry (%) Zcase Zcase-control
All SNPs
(1890 SNPs)
1.8 2.1 2.8
SNPs.1cM
(1236 SNPs)
1.8 2.8 2.6
Odd SNPs 1.9 2.4 3.0
Even SNPs 1.1 1.7 2.1
Female, all SNPs 3.2 3.1 2.3
Male, all SNPs 1.5 1.3 1.1
doi:10.1371/journal.pone.0001244.t003
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Figure 2. The Z-scores and 39 missense SNPs on chromosome 6. The region represents 18.3 Mb with Z-score .1,0. (in black): case-only Z score (in
red) : case-control Z score; small vertical bars on the X-axis represent the location of the 39 missense SNPs.
doi:10.1371/journal.pone.0001244.g002
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PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1244genotype. Figure 3 presents African ancestry at the peak location
for people who carry TT compared to the remaining genotypes
between cases and controls. As expected, we observed a significant
excess of African ancestry between cases and controls who were
TT (p=0.00045) but not those that were TC and CC (p=0.34).
These results suggest that rs2272996 is a potential candidate to
explain the admixture mapping evidence. When we added
rs2272996 in an admixture mapping analysis and the Z score at
rs227299 did not improve. This result is reasonable because the
information content after adding rs2272996 does not increase,
given the AIMs used in this region.
We then analyzed rs2272996 by assuming a recessive model in
both European Americans and Mexican Americans using logistic
regression with adjustment for gender, age, age
2, and BMI. We
observed significant evidence of association between rs2272996
and hypertension in Mexican Americans (p=0.021), where the
TT genotype increased the risk of hypertension (Table 5). Among
European Americans, on the other hand, a similar analysis
demonstrated the opposite–albeit non-significant–association (TT
genotype protective, odds ratio=0.79 (p=0.089). This result is
consistent with the findings in African Americans, where the
association increased when analysis was limited to individuals with
.80% African ancestry at the peak by admixture mapping. We
then estimated the population attributable risk of rs2272996 in the
African-American and Mexican populations. Under the recessive
model we obtained a population attributable risk of 16% in
African-Americans, and 35% in Mexican-Americans; this result
occurs because T-the risk allele–is relatively common in both
populations.
DISCUSSION
Admixture mapping has been proposed as an alternative to
traditional linkage and association studies and in theory holds
great promise for selected traits [20–29]. In the first application of
this strategy to mapping complex traits, Zhu et al. performed
a genome-wide admixture mapping of hypertension in an African-
American sample based on a set of microsatellite markers designed
for traditional linkage analysis and identified two regions on
chromosome 6 and 21 that potentially harbored hypertension
susceptibility genes [1]. Reich et al. [32] also reported a locus on
chromosome 1 associated with multiple sclerosis by admixture
mapping. More recently, linkage analysis followed by fine
mapping identified a chromosome region harboring genes for
susceptibility to prostate cancer [34] and this locus was sub-
sequently replicated with admixture mapping [35]. In this report
we present additional evidence from genome-wide admixture
mapping for hypertension in 1743 unrelated African Americans
using a highly informative SNP panel [31]. This panel extracted
on average 89% of the information of ancestry (measured by SIC)
[25] for the African-American sample and as a consequence the
results from both case-only and case-control tests were reasonably
robust. Our estimate of the average information for ancestry is
higher than was found in the original report for this SNP panel
[31]. This may be explained by the fact that we assumed a 50%–
50% mixture when no SNPs are genotyped while Smith et al.
assumed a 79%–21% mixture. Under the latter assumption the
estimated average information was 65%, slightly less than the 71%
suggested by Smith et al. [31]. The estimated ancestral allele
frequencies in the parental populations are close to the
corresponding observed frequencies in contemporary African
and European populations, suggesting that our model fits the
data well. We observed 6 regions with consistent excess of African
or European ancestry in both case-only and case-control analyses,
including the region on chromosome 6 identified in our previous
study [1]. However, simulation studies indicate that we did not
find any region that reaches genome-wide significance in this
study. Although the regions on chromosome 6 and 21 identified in
our previous study are large (37cM and 30 cM, respectively), our
simulations indeed suggest that the present result is unlikely to be
due to chance. It is interesting that we observed stronger evidence
but less significant association with the African-derived allele on
chromosome 6 than on chromosome 21. Several reasons may
explain this outcome. 1) The power of admixture mapping is
dependent on the underlying genetic model, with the recessive
mode of inheritance being more powerful than additive or
dominant modes [21]. A recessive effect for the T allele of
missense SNP rs2272996 in VNN1 gene best explains the
evidence, suggesting it is reasonable to observe better admixture
mapping evidence on chromosome 6 than 21. 2) The power of
admixture mapping is dependent on the disease allele frequency
Figure 3. African ancestry in cases and controls grouped by
genotypes of SNP rs2272996. A significant excess of African ancestry
between cases and controls who were TT was observed but among
those that bore the genotype TC and CC.
doi:10.1371/journal.pone.0001244.g003
Table 4. Two SNPs identified by logistic regression analysis assuming additive model at significance level 0.05. Gender, Age, age
2,
BMI and African ancestry were adjusted. Minor allele was coded as the risk allele.
..................................................................................................................................................
Adjust for ancestry African Ancestry.80%
SNPs Genes MAF (AA) EA HA
YRI
HapMap
CEU
HapMap
Odds ratio
(95% CI) P-value
Odds ratio
(95% CI) P-value
Rs2244008(A/G)
(T2636A)
LAMA2 11.4(G) 7.8 7.3 7.5 5.8 0.76(0.6, 0.96) 0.023 0.72(0.54,0.95) 0.021
Rs2272996(C/T)
(N131S)
VNN1 18.0(C) 27.6 18.4 18.3 34.2 0.81(0.67,0.95) 0.035 0.68(0.53,0.87) 0.00248
doi:10.1371/journal.pone.0001244.t004
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PLoS ONE | www.plosone.org 5 November 2007 | Issue 11 | e1244difference between two ancestral populations, while the power of
association is dependent on the linkage disequilibrium between the
underlying disease variant and the test marker, which is the ancestry
in this case, and the disease allele frequency in the admixed
population. We performed a power analysis by assuming that the
missense SNP rs2272996 is the true causative variant. We further
assumed that the odds ratio of the TT genotype vs others in African
ancestry population is 1.57, as estimated in Table 5. Since we failed
to observe evidence of association in the European American
population, the odds ratio was simply placed at 1.0, which leads to
the estimate of the relative population risk ratio of 1.38. Under these
assumptions, our power analysis suggests that, post hoc, we had 38%
power to detect a region reaching the genome wide significance with
the sample size in the current study. Thus, our study clearly has
relatively low power to find similar locus. 3) A spurious finding is still
possible because of the statistical fluctuation despite our previous
report. Further association analysis is necessary to rule out the
possibility that this is a false positive finding.
We performed our analysis based on a method which directly
maximizes the likelihood function from the hidden Markov Model
using the EM algorithm, allowing for uncertainty in model
parameters, such as the allele frequencies in the parental
populations [25]. Simulations suggested that this method can
perform as well as the widely used Bayesian MCMC method
STRUCTURE for the data generated from various population
admixture models.[25] However, we believe the results can be
regarded with greater confidence if different approaches lead to
similar results, as suggested by others [36]. We thus performed
similar analysis using STRUCTURE, although we are also aware
that other similar MCMC based software has become available
[22–24]. The difference between ADMIXPROGRAM and
STRUCTURE includes the approach to estimation of a large
number of parameters, eg, ADMIXPROGRAM directly maxi-
mizing the likelihood function based on EM algorithm while
STRUCTURE uses a Gibbs sampling scheme. The other
difference involves the transition probability in the Hidden
Markov model. ADMIXPROGRAM uses the transition proba-
bility derived from a continuous-gene-flow model and STRUC-
TURE uses linkage model by assuming that chunks of chromo-
somes are derived from ancestral populations and the breakpoints
between successive chunks occur randomly [25,37]. Despite the
substantial difference of the two approaches, the results are almost
identical, providing further confidence that our results are not
biased of the selection of the statistical method.
Several publications [22,23,25,26,38] have demonstrated that
admixture mapping can be seriously biased by background LD
between adjacent SNPs when this phenomenon is not properly
considered. We thus examined the background LD in European
Americans and dropped the SNPs that are in strong LD. Since the
maker panel was initially selected to minimize background LD,
eliminating additional selected markers based on this characteristic
had a very limited effect. We further repeated the analyses using
different sets of SNPs: (eg, odd or even SNPs , those with adjacent
distance.1 cM) and the results on chromosome 6 were essentially
the same. We note, however, that more information might have
been obtained by keeping those SNPs that were in LD when using
the Markov Hidden Markov Model method recently proposed by
Tang et al.[26].
We next followed up the region on chromosome 6 by
genotyping 51 missense SNPs in 36 genes spaced across the 18.3
Mb region. Searching for disease variants by testing all functional
SNPs has been advocated by Risch [5] and Risch and Botstein
[33] and this strategy successfully identified the sixth type 1
diabetes locus by examining all functional SNPs across the genome
[13]. We adapted this strategy in the chromosome 6 region and
identified a missense SNP rs2272996 (or N131S) in the VNN1
gene significantly associated with hypertension in African Amer-
icans after adjusting for multiple comparisons; this association was
replicated in Mexican Americans. A non-significant association in
the opposite direction was observed in European Americans. (No
correction was made for multiple comparisons in Mexican
Americans and European Americans since we tested only
rs2272996 in these two populations.) Further analysis also
indicates that this SNP accounts for most of the evidence of
excess of African ancestry observed in this region for African
Americans. Thus, the association of SNP rs2272996 to hyperten-
sion is unlikely to be due to chance alone, although additional
replication studies in independent studies are necessary. It should
also be noted that our search of causative variants was not
comprehensive and other susceptibility variants may well exist in
this region.
We were also puzzled by the direction of the risk estimate
associated with allele T in different populations. Theory suggests
that the divergent risk relationship at this locus in ancestral
populations will increase the power of admixture mapping
method. However, the different patterns of risk in these
populations cannot be explained with the data currently available,
but could reflect gene-gene or gene-environmental interactions
[39]. It is possible that this locus was under different selective
pressure in different populations, however, the evolutionary
processes that have molded susceptibility to chronic cardiovascular
disease have not been defined. Whether the at-risk alleles arose
under positive selection or a neutral-equilibrium model therefore
cannot be determined. The suggestion has been made that
susceptibility variants for hypertension may have been under
selection pressure due to the climate adaptation, however most of
Table 5. Analysis of rs2272996 in African Americans, Mexican Americans and European Americans using recessive model (TT vs TC,
CC). Gender, Age, age
2, BMI and African ancestry were adjusted. Allele T was coded as the risk allele.
..................................................................................................................................................
Odds ratio (95% CI) P-value Freq of T allele
cases controls
African Americans
Adjusting for ancestry (all people
included)
1.29(1.03,1.61) 0.0296 0.832 0.808
People with African ancestry.80% 1.57(1.18,2.09) 0.0021 0.840 0.804
Mexican Americans 1.82 (1.09, 3.02) 0.021 0.856 0.805
European Americans 0.79 (0.60, 1.04) 0.089 0.696 0.739
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
VNN1 with Hypertension
PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1244the loci identified under this assumption have not been replicated
in association analyses [40–42]. Under this model, the variants are
unlikely to be deleterious and could be common. Voight et al.[43]
proposed a method to detect signals of very recent positive
selection in the human genome using HapMap data and the
VNN1 gene is located in one of the regions with strong positive
selection pressure in YRI sample. VNN1 belongs to the vanin
family of proteins, including secreted and membrane-associated
proteins which have been reported to participate in hematopoietic
cell trafficking and to possess pantetheinase activity which may
play a role in oxidative-stress response [44]. It has been recently
suggested that increased oxidative stress may antedate hyperten-
sion and contribute to its pathogenesis [45]. More recently, VNN1
has been suggested as a novel gene for cardiovascular disease risk,
strongly associated with expression levels of several lipid
metabolism/CVD-risk genes, [46,47] although the underlying
pathway of VNN1 and other CVD-risk genes remains unknown.
In summary, we conducted a genome-wide search for
susceptibility loci for hypertension using admixture mapping in
African Americans. Further association studies identified a mis-
sense SNP rs2272996 in the VNN1 gene that may explain the
evidence identified through admixture analysis. While requiring
further confirmation, this finding demonstrates the potential for
the admixture approach and suggests it could be a tool for use in
studies to define genes affecting selected complex traits. In
addition, our study only surveyed the non-coding SNPs on the
region on chromosome 6. A more comprehensive assessment of
variants in this region will be required to provide assurance that
the causative variants associated with hypertension have been
identified.
MATERIALS AND METHODS
Samples
The design and methodology of the Dallas Heart Study have been
reported elsewhere [48]. In brief, a multistep probability sample of
civilian, non-institutionalized English- or Spanish-speaking Dallas
County residents were recruited from households. African
Americans were oversampled to ensure that they represented
50% of the final cohort. Eligible subjects were invited to
participate in three stages of the project including two home visits
during which a survey was administered and blood and urine
specimens were obtained and a third visit at the University of
Texas at Southwestern Medical Center during which imaging
studies were accomplished. Three thousand three hundred and
ninety eight individuals (52% black) participated in the blood
drawing that led to DNA isolation. Informed consent was obtained
from all participants and the Institutional Review Board of the
University of Texas Southwestern Medical Center approved the
study protocol.
Race-ethnicity was based on self-identification. Subjects were
asked in separate questions ‘‘Are you of Mexican American
origin’’ and ‘‘What is your primary racial or ethnic identity.’’ The
following options were provided for the latter question: Black/
African American; White/Caucasian; American Indian, Alaska
Native; Asian, Pacific Islander, East Indian; Other (Specify). Self-
identified whites were used as a proxy for the European founding
populations in the genetic analyses.
Phenotype
Blood pressure/hypertension At each of the three visits
(home visits 1 and 2 and visit 3), 5 sets of blood pressure
measurements were obtained using an automatic oscillometric
device (Welch Allyn, Series #52,000, Arden, NC) with an
appropriately sized blood pressure cuff. This device has been
validated against catheter measurement of arterial pressure [48].
The BP for analysis was considered the average of measurements 3
through 5 at each visit (total 9 readings). Hypertensive cases were
defined as persons with either a systolic BP.=140 or diastolic
BP.=90, or current treatment with an antihypertensive
medication.
Genotyping
For each subject, DNA sample was individually genotyped by
Perlegen Sciences for the complete marker set defined by Smith et al
[31]. Among them, 2,270 SNPs were successfully genotyped. Fifty
one additional missense SNPs in 36 genes on chromosome 6 were
identified from National Center for Biotechnology Information
(NCBI) build 34, and then genotyped by Perlegen Sciences.
Selection of admixture marker set
Hardy-Weinberg equilibrium (HWE) was first examined for all the
2,270 successfully genotyped SNPs on 22 autosomes in the three
populations separately using the software Haploview [49]. Thirty
two SNPs were identified with significant departure from HWE at
significance level a,0.001 and were excluded in future analyses.
To study the LD in the ancestral populations, pairwise linkage
disequilibrium defined by D’ values between SNPs on the same
chromosome was calculated using the software Haploview in
Whites. We identified 251 sets of adjacent SNPs in strong LD
(95% lower bound D’.0.5). Since strong LD between adjacent
markers can seriously bias the estimation of marker location-
specific ancestry [26], we retained only one SNP from each of
these sets in the subsequent analyses. After these data verification
procedures, we defined an analytic set of 1,890 from the original
2,270 SNPs. These SNPs were entered in the hidden Markov
model (HMM) to estimate the marker locus specific ancestry in
African-Americans based on EM algorithm using software
ADMIXPROGRAM [25].
Estimation of marker location-specific ancestry
The genome-wide admixture mapping analysis was only per-
formed in African-Americans since the SNP set of Smith et al. was
specifically selected for the African-American population. We
estimated marker location-specific ancestry using the HMM, in
which the transmission probability was calculated based on the
continuous gene flow (CGF) model [21,25]. This method directly
maximizes the likelihood function through an EM iterative
algorithm and allows consideration of uncertainty of marker allele
frequencies in the parental populations [25]. The number of
generations since population admixture was estimated by
maximizing the likelihood function for the number of generations.
To estimate the marker location-specific ancestry, we assumed
there were two parental populations for the African-American
population. If our model fit the data well, we would expect the
estimated allele frequencies in ancestral African and European
populations to be close to what is observed in contemporary
populations, although not the same. To allow for the uncertainty
of ancestral marker allele frequencies, we compared the estimated
ancestral allele frequencies and marker location-specific ancestries
when no ancestral population information was used to a situation
where only observed European allele frequencies were used as the
initial European ancestral allele frequencies in the model. The
results were essentially the same and we then reported the results
using the European allele frequencies. The correlation between
the observed and estimated allele frequencies in the European
sample was 97.1% and the correlation between estimated African
VNN1 with Hypertension
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et al [31] (calculated from the weighted average allele frequencies
of Ghana and Cameroon) was 84.5% (figure 4 A and B). The
lower correlation for African allele frequencies is apparently due to
inconsistent designation of the minor allele. However, this
inconsistency has no effect to the results because no African
ancestral information was used in our analysis.
Testing for linkage by admixture mapping
To test for linkage we calculated two test statistics: the Z score of the
case-only test and the Z score of the case-control test [21,25]. We
also estimated the marker location-specific ancestry using the
software STRUCTURE [31,50]. STRUCTURE was run under
the linkage model without haplotype phase information, with 50,000
burn-in iterations followed by an additional 50,000 iterations. We
specified SITEBYSITE=1 and STRUCTURE provided output for
the joint posterior assignment probabilities of population origin for
the two alleles at each marker location. We next compared the
marker-specific ancestry obtained with the software STRUCTURE
to the results obtained from the EM method.
Simulation of admixture populations
We directly simulated admixed populations according to the
continuous gene flow model [21,25]. The ancestral allele
frequencies, the number of generations since the occurrence,
and average ancestry were based on the estimates in the African
American samples. To simulate African-American samples, at the
first generation the marker genotypes of 10,000 unrelated people
were simulated according to the African allele frequencies
assuming HWE and independence of the markers. An admixed
population was then formed by taking a proportion of 3.3%
randomly selected from the simulated population to mate with
people generated according to the marker allele frequencies in the
European population, with the remaining individuals randomly
mating among themselves. The number of children produced by
each marriage was assumed to follow a Poisson distribution with
mean size 2. The number of crossovers between two marker loci at
a distance d cM was assumed to follow a Poisson distribution with
mean d/100. This process was repeated in the following
generations to form the current African American populations.
Testing association between and marker and
hypertension
We applied a logistic model regressing hypertension status on
gender, age, age
2 and the genotype effect assuming additive
model. For African Americans, individual ancestry estimated by
HMM was included in the model. For Mexican Americans, we
applied the genome-control method [51] to control for population
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Figure 4. Ancestral allele frequencies. A. European ancestral allele frequencies estimated by Hidden Markov Model in the African-American sample
vs the observed allele frequencies in European Americans. B. African ancestral allele frequencies estimated by Hidden Markov Model in the African-
American sample vs the observed allele frequencies by the weighted average from Ghana and Cameroon obtained from Smith et al. (2004).
doi:10.1371/journal.pone.0001244.g004
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significant association were further analyzed using different models
of inheritance.
Permutation test
To obtain the significance level of SNP rs2272996 in VNN1
accounting for multiple tests, we performed permutation tests for
those SNPs with allele frequency difference between African
Americans and Europeans greater than that of SNP rs2272996.
We permutated the hypertension status together with gender, age,
BMI and African ancestry 10,000 time and analyzed the
individuals whose African ancestral.80% at each permutation.
Logistic regression was then performed for each SNP and the
minimum P-value was recorded at each permutation. These
minimum P-values were tallied to obtain the null distribution of
the test adjusting for multiple tests.
SUPPORTING INFORMATION
Table S1 Individual European Ancestral estimated by ADMIX-
PROGRAM and STRUCTURE
Found at: doi:10.1371/journal.pone.0001244.s001 (0.14 MB
XLS)
Table S2 Case-only and case-control Z-scores across the
genome
Found at: doi:10.1371/journal.pone.0001244.s002 (0.46 MB
XLS)
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